In adults, there is evidence that intermittent fasting is effective in the short-term (eight weeks to six months) to help individuals with obesity lose body weight (4%–8%) and body fat, and improve insulin sensitivity and other risk factors for T2DM [50,51,52,53,54,55,56,57,58,59,60]. This evidence concerns the gene INS and obesity disorder.